Core Alternative Capital’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$96.5K Buy
2,262
+377
+20% +$20.5K 0.03% 131
2026
Q1
$118K Buy
1,885
+338
+22% +$27K 0.03% 124
2025
Q4
$148K Buy
1,547
+1,499
+3,123% +$147K 0.04% 119
2025
Q3
$4.69K Sell
48
-271
-85% -$28.1K ﹤0.01% 200
2025
Q2
$34.3K Hold
319
0.01% 144
2025
Q1
$32.2K Sell
319
-51
-14% -$5.13K 0.01% 151
2024
Q4
$33K Hold
370
0.01% 167
2024
Q3
$31K Hold
370
0.01% 170
2024
Q2
$28.5K Hold
370
0.01% 173
2024
Q1
$25.3K Sell
370
-611
-62% -$39.3K ﹤0.01% 175
2023
Q4
$56.7K Sell
981
-1,193
-55% -$63.7K 0.01% 159
2023
Q3
$115K Buy
2,174
+450
+26% +$23.6K 0.02% 136
2023
Q2
$93.3K Sell
1,724
-66
-4% -$3.45K 0.01% 125
2023
Q1
$89.6K Buy
1,790
+414
+30% +$19.5K 0.01% 120
2022
Q4
$63.7K Sell
1,376
-68
-5% -$2.94K 0.01% 139
2022
Q3
$56K Buy
1,444
+136
+10% +$5.46K 0.01% 137
2022
Q2
$49K Buy
1,308
+102
+8% +$4.15K 0.01% 150
2022
Q1
$53K Buy
1,206
+1,018
+541% +$44.1K 0.01% 143
2021
Q4
$8K Buy
+188
New +$7.9K ﹤0.01% 148

Other funds holding BSX

Core Alternative Capital's BSX Position: Q2 2026 in Review

Core Alternative Capital increased its Boston Scientific (BSX) stake by 20% in Q2 2026, buying an estimated $20.5K and bringing the position to 2,262 shares worth $96.5K. The position accounts for 0.03% of the portfolio, ranked #131.

Core Alternative Capital first reported a position in BSX in Q4 2021 and has held it in 19 quarters since. The position peaked at $148K in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Core Alternative Capital held 2,262 shares of Boston Scientific worth $96.5K as of Q2 2026.
  • Core Alternative Capital bought 377 Boston Scientific shares in Q2 2026, an estimated $20.5K.
  • Boston Scientific made up 0.03% of Core Alternative Capital's portfolio in Q2 2026, its #131 holding.
  • Core Alternative Capital first reported a position in Boston Scientific in Q4 2021 and has held it in 19 quarters since.
  • Core Alternative Capital's Boston Scientific position peaked at $148K in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Core Alternative Capital's 13F filing for Q2 2026, filed 14 Aug 2026.